Tag:
executive prosecutions
Latest Headlines
Latest Headlines
Feds to reply in Purdue execs' exclusion appeal
We could soon get an indication on the U.S. government's current thinking about pursuing individual healthcare executives for their companies' wrongdoing. An appeal in the highly publicized Purdue
HHS moves to bar Forest CEO from pharma
The FDA has been threatening to move against pharma executives whose companies stray outside the law. Perhaps out of frustration with repeated off-label marketing violations, agency officials have
New law may mean harsher exec sentencing
Let's say you're a pharmaceutical company executive. You could still end up in an orange felony jumpsuit if somone in your company violates the Food, Drug & Cosmetic Act--even if you weren't
FDA exec litigation guide skirts transparency effort
So much for transparency! The long-awaited FDA guidelines for Park Doctrine executive prosecutions effectively shut out drugmakers from the agency's thinking on when jail time might drive compliance
FDA's no-criteria criteria for prosecuting execs
The FDA has been warning for months now that individual pharma executives could be prosecuted when their companies disobey the rules. Naturally, drugmakers and lawyers want more info on the agency's
Emboldened FDA struts before pharma
Warning letters commanded greater attention in 2010 than in recent memory. Consent decrees and executive prosecutions also rose in status. Warning letters have gotten more specific. A tone of
FDA looks to prosecute 'two-legged defendants'
We've heard a lot of talk lately about the feds cracking down on pharma executives. In the wake of a series of off-label marketing settlements, FDA and Justice Department officials have been talking
